Dr. Agarwal's Eye Hospital Limited (BOM: 526783)
India
· Delayed Price · Currency is INR 4,947.60
+171.30 (3.59%)
At close: Nov 14, 2024
Dr. Agarwal's Eye Hospital Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 504.9 | 463.6 | 369.2 | 241 | -14.39 | 136.83 | Upgrade
|
| Depreciation & Amortization | 335.6 | 265.2 | 199.2 | 199.6 | 180.79 | 194.98 | Upgrade
|
| Other Amortization | 0.9 | 0.9 | 2.6 | 4.3 | 10.21 | 17.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4.3 | 2.3 | -0.3 | -2.2 | 0.2 | 1.2 | Upgrade
|
| Provision & Write-off of Bad Debts | 17.7 | 8.6 | 8 | 13.2 | 19.59 | -4.27 | Upgrade
|
| Other Operating Activities | 62.7 | 57.3 | 68.1 | 49.7 | 100.61 | 67.28 | Upgrade
|
| Change in Accounts Receivable | -82.5 | -37.1 | -19.8 | -12.2 | -39.67 | 22.95 | Upgrade
|
| Change in Inventory | -37.6 | -37.5 | -2.7 | -5.1 | 27.62 | -14.87 | Upgrade
|
| Change in Accounts Payable | 16.9 | 68.6 | 10.3 | 83.4 | 57.41 | -44.69 | Upgrade
|
| Change in Other Net Operating Assets | 24 | 105.8 | 61.6 | -4.9 | -3.63 | 9.4 | Upgrade
|
| Operating Cash Flow | 841.8 | 897.7 | 696.2 | 566.8 | 338.73 | 386.19 | Upgrade
|
| Operating Cash Flow Growth | 3.10% | 28.94% | 22.83% | 67.33% | -12.29% | 54.05% | Upgrade
|
| Capital Expenditures | -857.3 | -713.1 | -703.4 | -467.3 | -111.82 | -171.39 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.4 | 10 | 0.7 | 3.2 | 1.64 | 4.26 | Upgrade
|
| Sale (Purchase) of Intangibles | -14.1 | -0.1 | - | - | - | - | Upgrade
|
| Investment in Securities | -129.8 | - | - | - | - | - | Upgrade
|
| Other Investing Activities | -4.2 | 2.8 | -3.4 | 1.3 | 0.5 | 0.42 | Upgrade
|
| Investing Cash Flow | -1,179 | -700.4 | -706.1 | -462.8 | -109.68 | -166.72 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 30 | 75.13 | - | Upgrade
|
| Long-Term Debt Issued | - | 150 | 209.4 | 257.5 | 43.22 | 4.9 | Upgrade
|
| Total Debt Issued | 465.1 | 150 | 209.4 | 287.5 | 118.35 | 4.9 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -38.7 | -54.44 | -2.77 | Upgrade
|
| Long-Term Debt Repaid | - | -264.2 | -174.9 | -268.8 | -116.05 | -162.32 | Upgrade
|
| Total Debt Repaid | -310.1 | -264.2 | -174.9 | -307.5 | -170.5 | -165.09 | Upgrade
|
| Net Debt Issued (Repaid) | 155 | -114.2 | 34.5 | -20 | -52.14 | -160.19 | Upgrade
|
| Common Dividends Paid | -37.7 | -25.8 | -14.1 | -0.2 | -0.36 | -7.05 | Upgrade
|
| Other Financing Activities | -5.2 | -2.3 | -17.8 | -17.9 | -23.5 | -32.16 | Upgrade
|
| Financing Cash Flow | 112.1 | -142.3 | 2.6 | -38.1 | -76 | -199.39 | Upgrade
|
| Net Cash Flow | -225.4 | 55 | -7.3 | 65.9 | 153.05 | 20.09 | Upgrade
|
| Free Cash Flow | -15.5 | 184.6 | -7.2 | 99.5 | 226.91 | 214.8 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -56.15% | 5.64% | 7788.40% | Upgrade
|
| Free Cash Flow Margin | -0.43% | 5.78% | -0.27% | 4.95% | 16.17% | 12.12% | Upgrade
|
| Free Cash Flow Per Share | -3.30 | 39.28 | -1.53 | 21.17 | 48.28 | 45.70 | Upgrade
|
| Cash Interest Paid | 5.2 | 2.3 | 17.8 | 17.9 | 23.5 | 30.72 | Upgrade
|
| Cash Income Tax Paid | 139 | 136.1 | 115.2 | 89.3 | 33.25 | 68.85 | Upgrade
|
| Levered Free Cash Flow | -208.18 | 104.08 | -171.21 | 12.45 | 207.48 | 149.84 | Upgrade
|
| Unlevered Free Cash Flow | -142.61 | 148.45 | -128.71 | 50.7 | 245.8 | 196.03 | Upgrade
|
| Change in Net Working Capital | 89.1 | -166.6 | -20.6 | -81.04 | -92.75 | 12.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.